#London #United Kingdom #gene therapy #Biotech Innovation #Craig Mello

The Future of Cell and Gene Therapy: Insights from the GenScript Biotech Global Forum

On November 20, the vibrant city of London will turn into the hub for cell and gene therapy (CGT), bringing together leading figures from the scientific, biotech, and investment communities. The GenScript Biotech Global Forum 2025 promises an engaging experience, as prominent voices in the field will gather to discuss the rapid advancements and challenges in CGT.

This forum will be held alongside the Jefferies London Healthcare Conference, both focusing on the theme "THE NEXT ERA OF CGT IS HERE." The goal is to convert groundbreaking scientific discoveries into tangible benefits for patients, exploring the route from research to clinical application.

A Platform for Experts: Keynote Speakers and Panels

A central feature of this event is the keynote address by Dr. Craig Mello, a Nobel Laureate in Physiology or Medicine in 2006. As a co-discoverer of RNA interference (RNAi), Dr. Mello has significantly impacted genetic research and the development of RNA-based therapeutics. His talk, titled "RNAi A Molecular Spark in an Information Inferno," will reflect on professional lessons learned throughout his career in CGT and its implications for future innovations.

In addition to Dr. Mello, Dr. Miguel Forte, the President of the International Society for Cell & Gene Therapy (ISCT), will present insights into the clinical translation of CGT, focusing on regulatory strategies necessary for overcoming existing challenges. His panel discussion on navigating barriers to wider therapeutic access and scalability is expected to resonate strongly with attendees.

The forum will feature a series of panels that delve into pressing topics in the CGT field:

1. Navigating the Future of Cell Therapy: This session will explore innovative pathways in cell therapy, spotlighting advancements in autologous and allogeneic platforms, as well as next-generation technologies harnessing artificial intelligence. Notable panelists include Ying Huang (CEO, Legend Biotech) and Paul Stoffels (Former CSO, Johnson & Johnson).

2. Gene Therapy and mRNA Therapeutics: Discussions will focus on contemporary challenges regarding safety and delivery mechanisms in mRNA-based treatments. Experts like Sergio Linares from Sanofi and Luigi Calzolai of the European Commission Joint Research Centre will share their insights.

3. From Lab to Patient: Manufacturing Challenges: This panel, featuring industry veterans like Jin Yin (CTO, ProBio) and John Maher (CSO, Leucid Bio), will tackle the complexities surrounding the manufacturing process in CGT, providing insights on reproducibility and regulatory compliance.

4. Innovation and Investment in CGT: Investment strategies that ensure sustainable growth in CGT industries will be analyzed. Leading investors such as Laura Stoppel of RA Capital Management and Michiel Broker from UBS will highlight the financial landscape in this evolving sector.

Networking and Collaboration Opportunities

The day will not only focus on expert presentations but also include various networking opportunities, encouraging meaningful dialogue amongst attendees. A reception at the end of the day will provide a platform for further discussion, allowing networking among the scientific community, policymakers, and the investment sector.

Last Call for Registration

This is the final announcement regarding registration for the event. Complimentary tickets to the GenScript Biotech Global Forum are limited and will close soon. Individuals interested in attending can RSVP at this link using the registration code GSGM4 for a complimentary ticket (limited to the first 20 registrants).

Event Details

• - Date: November 20, 2025
• - Location: 116 Pall Mall, London, UK

With numerous breakthroughs anticipated in CGT, this forum represents a vital opportunity for networking, learning, and contributing to discussions on the future of medicine. Don’t miss your last chance to secure your place!